|CHU Liège - Hemato||JAK2 exon 12 mutation analysis||Dr Frédéric Lambert||
Fresh EDTA anticoagulated bone marrow (3 ml) (NOT BLOOD !!!).
Test performed IF EPO serum level low OR suggestive bone marrow trephine biopsy AND IF JAK2 V617F is not present.
Copy of those tests results should be provided to Fred Lambert.
|UZ Leuven MolPLUZ||JAK2 exon 12 mutation analysis||Lucienne Michaux / Els Lierman||
Sample type: blood / bone marrow (EDTA, 2-5 ml)
Test type: PCR on DNA + Sanger sequencing (in house method).
|UZ Gent||JAK2 exon 12 mutation analysis||Karl Vandepoele,
Joni Van Der Meulen,
In-house developed NGS panel to screen clinically relevant genes in MPN and MDS/MPN overlap:
CALR, CSF3R, JAK2, MPL, SETBP1 and SRSF2
Also available in a cost-effective mini-panel: JAK2, CALR and MPL
Version date: 18/08/2017